Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
DW-MSC 输注对低临床风险 COVID-19 感染患者的安全性:一项随机、双盲、安慰剂对照试验
期刊:Stem Cell Research
影响因子:7.1
doi:10.1186/s13287-022-02812-4
Muhammad Karyana #, Irawaty Djaharuddin #, Lutfah Rif'ati, Mansyur Arif, Mi Kyung Choi, Nova Angginy, Aeri Yoon, Jumi Han, Fonny Josh, Dona Arlinda, Asvin Narulita, Faisal Muchtar, Rizki Auliah Bakri, S Irmansyah